0.60Open0.70Pre Close50 Volume163 Open Interest5.00Strike Price3.00KTurnover87.11%IV7.17%PremiumAug 16, 2024Expiry Date0.26Intrinsic Value100Multiplier25DDays to Expiry0.34Extrinsic Value100Contract SizeAmericanOptions Type-0.5424Delta0.3678Gamma8.24Leverage Ratio-0.0082Theta-0.0019Rho-4.47Eff Leverage0.0049Vega
CorMedix Stock Discussion
Dow Jones· 4 mins ago. CorMedix: DefenCath Catheter Lock Solution Is FDA Approved to Reduce Incidence of Catheter-Related Bloodstream Infections in Adult Patients With Kidney Failure >CRMD
Dow Jones· 2 mins ago
Benzinga· just
CorMedix Receives FDA Approval For Defencath - moomoo
No comment yet